Drug-maker row escalates as Serono ignores court order

Article Abstract:

The article discusses how even though Biogen Inc. has obtained a Swiss court order preventing Serono AG from claiming superior effectiveness for its Rebif drug for multiple sclerosis, Serono gave a presentation anyway at a scientific conference in London.

Legal issues & crime, Switzerland, Central Nervous System Prep, Cases, Central nervous system agents, Serono AG

---

Novartis drug gets EU approval

Article Abstract:

The European Union has approved Novartis AG's anti-diabetes drug Galvus, a DPP-4 inhibitor for treating Type 2 diabetes. However, the drug faces a delay in the US, as the Food and Drug Administration has requested more clinical reports.

Europe, Government domestic functions, Government regulation, New Products/Services, Antidiabetic Preparations, Novartis AG, European Union, Hypoglycemic agents, Licensing, certification and accreditation, United States. Food and Drug Administration, Pharmaceutical policy, NVTSY, Health policy, Galvus (Medication)

---

Medicines Co. Gets U.S. FDA Approval For Anticlot Drug

Article Abstract:

The U.S. Food and Drug Administration has approved Angiomax, a new anticlotting drug which is manufactured by Medicines Co. Cambridge, Mass.-based Medicines obtained the rights for the drug from Cambridge, Mass.-based Biogen Inc.

Biological Product (except Diagnostic) Manufacturing, Strategic alliances, Drugs, Biological Products, Pharmaceutical Preparations, Blood Pressure Preparations, Licensing agreements, Antihypertensive agents, The Medicines Company, MDCO

Similar abstracts:

• Abstracts: Comverse reduces its profit estimates for quarter, year. Cendant agrees to buy Avis for up to $1 billion. Gore asks for patience, challenges certification
• Abstracts: AstraZeneca gets close to end of auction of unit. Novartis AG emerges as suitor for Monsanto. Abbott Will Acquire BASF's Knoll Unit
• Abstracts: Ingram Micro shares fall 31% as CEO says he'll quit. In electronics, U.S. companies seize momentum from Japan
• Abstracts: Red Herring Plans Its Second Round Of Staff Reductions. Dow Jones to cut newspaper jobs in Europe. Red Herring to lay off staff

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.